Update 10/19/2021: OSHA hosted meetings with industry stakeholders throughout the day on October 18 and 19 as the COVID-19 vaccine and testing ETS move towards approval by the Office of Management and Budget (OMB).
OSHA has seen a 581% uptick in coronavirus-related work safety complaints in the last two months, with the majority of complaints stemming from states in the Southeast, according to Agency data.
Last week, Oregon OSHA revised the mask requirements in the state's final COVID-19 worker protection regulations and issued two new temporary administrative orders to expand upon the final standard.
OSHA recently cited a medical facility in Lakewood, NJ for allegedly failing to ensure the safety and health of nurses giving flu shots and testing potentially infectious patients for the coronavirus.
OSHA issued two citations to a New Jersey-based healthcare provider for allegedly failing to protect employees from coronavirus-related hazards, resulting in the deaths of two workers.
California's revised rule took effect on June 17. These new regulations more closely align to CDC's most recent recommendations on COVID-19 workplace safety.
By July 6, 2021, healthcare industry employers must comply with most of the provisions in OSHA's new emergency temporary standard (ETS) to protect workers from COVID-19 exposure.
Newly updated OSHA guidance clarifies whether or not an employee's reaction to the COVID-19 vaccine is considered a recordable illness per 29 CFR 1904.
OSHA issued a $12,288 safety citation to a warehousing and distribution company in Naperville, IL for alleged safety violations related to a company meeting that led to 23 workers contracting COVID-19, including one who died.
OSHA delivered its COVID-19 Emergency Temporary Standard to Office of Management and Budget (OMB) for review and approval this week. If approved, the Final Rule may appear in the Federal Register within weeks.
What to do before, during, and after a RCRA hazardous waste inspection to defend your site from rising State and Federal penalties.